Published in J Korean Med Sci on June 01, 2008
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther (2009) 1.57
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer. Br J Cancer (2011) 1.07
The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer. BMC Cancer (2013) 0.82
Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol (2010) 0.80
The prognostic value of haplotypes in the vascular endothelial growth factor a gene in colorectal cancer. Cancers (Basel) (2010) 0.78
C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma. BMC Res Notes (2014) 0.76
Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients. World J Gastrointest Oncol (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet (2003) 26.59
Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42
Denaturing high-performance liquid chromatography: A review. Hum Mutat (2001) 3.58
Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine (2000) 3.22
Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res (2001) 2.85
A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res (2001) 2.70
A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes (2002) 2.46
A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci U S A (2002) 2.16
Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res (2002) 2.09
Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation (1996) 2.04
Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res (2003) 1.88
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer (2003) 1.88
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer (2004) 1.55
Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.29
Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian "tumor of breast tissue: incidence, genetics, and environmental risk factors" study. Breast Cancer Res Treat (2007) 1.28
Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun (2005) 1.19
TNM staging for malignancies of the digestive tract: 2003 changes and beyond. Semin Surg Oncol (2003) 1.18
Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res (1998) 1.17
Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy. Bioessays (2002) 1.03
VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford) (2004) 1.03
Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. Urology (2003) 0.97
Tumor markers and colorectal cancer: utility in management. J Surg Oncol (2003) 0.95
Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for oral cancer. Oral Oncol (2005) 0.93
DHPLC in clinical molecular diagnostic services. Mol Genet Metab (2005) 0.86
Vascular endothelial growth factor gene polymorphisms in Behçet's disease. J Rheumatol (2004) 0.86
What's new with tumor markers for colorectal cancer? Dig Surg (2000) 0.82
A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol (2012) 2.43
Telomere length and the risk of lung cancer. Cancer Sci (2008) 2.35
Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 2.26
Laparoscopic resection of extraperitoneal rectal cancer: a comparative analysis with open resection. Surg Endosc (2009) 2.13
The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet (2010) 1.90
Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma. J Hepatol (2004) 1.82
Multidimensional analysis of the learning curve for laparoscopic colorectal surgery: lessons from 1,000 cases of laparoscopic colorectal surgery. Surg Endosc (2008) 1.79
[A case of adenosquamous carcinoma of the papilla of Vater]. Korean J Gastroenterol (2006) 1.56
Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem (2002) 1.53
Clinical impact of early absolute lymphocyte count after allogeneic stem cell transplantation. Br J Haematol (2004) 1.50
Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers. J Thorac Oncol (2010) 1.43
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome. Acta Haematol (2015) 1.42
Outcomes of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients with monosomal karyotypes. Acta Haematol (2014) 1.39
Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine. Med Oncol (2010) 1.38
DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis (2004) 1.37
FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma. Blood (2006) 1.36
Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. J Control Release (2003) 1.34
Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res (2008) 1.32
Identification of the alphavbeta3 integrin-interacting motif of betaig-h3 and its anti-angiogenic effect. J Biol Chem (2003) 1.31
Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.29
Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int J Oncol (2006) 1.26
A novel approach of robotic-assisted anterior resection with transanal or transvaginal retrieval of the specimen for colorectal cancer. Surg Endosc (2009) 1.24
MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet Genomics (2007) 1.23
PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. Lung Cancer (2009) 1.22
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients. Cancer Genet Cytogenet (2007) 1.20
RGD peptides released from beta ig-h3, a TGF-beta-induced cell-adhesive molecule, mediate apoptosis. Oncogene (2003) 1.19
Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer (2007) 1.19
Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res (2012) 1.18
Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study. Haematologica (2010) 1.16
Preferences for and experiences of family involvement in cancer treatment decision-making: patient-caregiver dyads study. Psychooncology (2013) 1.15
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry. Int J Hematol (2013) 1.14
Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet (2006) 1.14
Cancer-associated splicing variant of tumor suppressor AIMP2/p38: pathological implication in tumorigenesis. PLoS Genet (2011) 1.12
Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features. Cancer (2007) 1.11
Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant. Eur J Haematol (2004) 1.09
Low-dose persistent organic pollutants increased telomere length in peripheral leukocytes of healthy Koreans. Mutagenesis (2010) 1.09
Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer. J Cancer Res Clin Oncol (2010) 1.09
Gallbladder lymphangioma: a case report and review of the literature. World J Gastroenterol (2007) 1.08
Comparison of one-stage managements of obstructing left-sided colon and rectal cancer: stent-laparoscopic approach vs. intraoperative colonic lavage. J Gastrointest Surg (2009) 1.08
microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3. Exp Ther Med (2011) 1.07
A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee). Clin Toxicol (Phila) (2005) 1.06
Polymorphisms in TGF-beta1 gene and the risk of lung cancer. Lung Cancer (2006) 1.05
XPC polymorphisms and lung cancer risk. Int J Cancer (2005) 1.03
Clinical implications of angiogenic factors in patients with acute or chronic leukemia: hepatocyte growth factor levels have prognostic impact, especially in patients with acute myeloid leukemia. Leuk Lymphoma (2005) 1.03
Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology (2012) 1.02
MDM2 309T>G polymorphism and risk of lung cancer in a Korean population. Lung Cancer (2006) 1.02
Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma. Clin Lymphoma Myeloma (2008) 1.02
Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. J Korean Med Sci (2008) 1.01
Polymorphisms in telomere maintenance genes and risk of lung cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.00
Expression of TGF-beta-induced matrix protein betaig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose. Kidney Int (2003) 1.00
Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer. Lung Cancer (2011) 1.00
Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer. J Clin Oncol (2009) 0.99
Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population. Lung Cancer (2007) 0.99
Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy. Lung Cancer (2013) 0.98
Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype. J Clin Oncol (2011) 0.98
betaig-h3 triggers signaling pathways mediating adhesion and migration of vascular smooth muscle cells through alphavbeta5 integrin. Exp Mol Med (2006) 0.98
Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas. Br J Haematol (2007) 0.97
Up-regulated transforming growth factor beta-inducible gene h3 in rheumatoid arthritis mediates adhesion and migration of synoviocytes through alpha v beta3 integrin: Regulation by cytokines. Arthritis Rheum (2006) 0.97
Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study. Mol Carcinog (2010) 0.97
-93G-->A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer (2004) 0.97
Diagnostic performance of the QuantiFERON-TB Gold In-Tube assay and factors associated with nonpositive results in patients with miliary tuberculosis. Clin Infect Dis (2014) 0.96
The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations. Hum Genet (2011) 0.96
A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer (2010) 0.95
New staging systems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation as first-line therapy. Biol Blood Marrow Transplant (2006) 0.95
Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study. BMC Cancer (2007) 0.95
Malignant peripheral nerve sheath tumor in neurofibromatosis type I: unusual presentation of intraabdominal or intrathoracic mass. Korean J Intern Med (2005) 0.95
Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population. Lung Cancer (2006) 0.95
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era. Ann Hematol (2012) 0.95
A common polymorphism in pre-microRNA-146a is associated with lung cancer risk in a Korean population. Gene (2013) 0.94
Regression of giant pseudopolyps in inflammatory bowel disease. J Crohns Colitis (2011) 0.94
Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia. Int J Cancer (2006) 0.93
Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology (2007) 0.93
EML4-ALK fusion gene in Korean non-small cell lung cancer. J Korean Med Sci (2012) 0.93